SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-028598
Filing Date
2024-02-08
Accepted
2024-02-08 18:24:28
Documents
2
Group Members
VERSANT VANTAGE I GP, L.P.VERSANT VANTAGE I GP-GP, LLCVERSANT VANTAGE I, L.P.VERSANT VENTURES VII GP, L.P.VERSANT VENTURES VII GP-GP, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d734506dsc13g.htm SC 13G 116125
2 EX-99.1 d734506dex991.htm EX-99.1 10455
  Complete submission text file 0001193125-24-028598.txt   128365
Mailing Address ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104 415-801-8100
Versant Venture Capital VII, L.P. (Filed by) CIK: 0001750266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 5505 MOREHOUSE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE, SUITE 300 SAN DIEGO CA 92121 (619) 937-2754
RayzeBio, Inc. (Subject) CIK: 0001825367 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94159 | Film No.: 24610571
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)